Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
National
Storm Newton

UNCOVERED: More info needed on weight loss jab s impact on type 2 diabetes nice - The Untold Story

PA Wire

More information is needed on a weight-loss jab’s effectiveness in treating type 2 diabetes before it is recommended for NHS use, the National Institute for Health and Care Excellence (Nice) has said.

The recommendation for tirzepatide, which is sold under the brand name Mounjaro and is developed by Eli Lilly, was issued in draft guidance issued by the public body.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.